Kevin Chung
Internal Medicine · Abington, PANPI 1194175323
Payments from drug & device makers
Across 75 payments — averaging $54.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abbott$642
- Abiomed$464
- Shockwave Medical, Inc$427
- Penumbra, Inc.$236
- AstraZeneca$224
- plus $909 from 13 others
What the payments were for
- Travel & lodging$48712%
- Food & beverage$2,83070%
- Education$74518%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $1,161 |
| Abbott | 11 | $642 |
| Abiomed | 11 | $464 |
| Shockwave Medical, Inc | 11 | $427 |
| Penumbra, Inc. | 2 | $236 |
| AstraZeneca | 2 | $224 |
| Astellas Pharma US Inc | 2 | $198 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $149 |
| Pfizer | 7 | $127 |
| Boehringer Ingelheim | 1 | $97 |
| Novartis | 4 | $60 |
| Amgen | 2 | $43 |
| Heartflow, Inc. | 2 | $42 |
| Merck | 3 | $41 |
| Johnson & Johnson | 2 | $41 |
| Philips North America LLC | 1 | $36 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Bayer | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,062 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $22,394 |
| EliquisApixaban | 16 | $13,921 |
| FarxigaDapagliflozin Propanediol | 16 | $8,854 |
| Atorvastatin Calcium | 71 | $1,018 |
| Nifedipine ErNifedipine | 22 | $771 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 28 | $623 |
| Bumetanide | 16 | $454 |
| ClopidogrelClopidogrel Bisulfate | 23 | $439 |
| Metoprolol Succinate | 29 | $407 |
| Carvedilol | 62 | $388 |
| Hydralazine Hcl | 27 | $279 |
| Valsartan | 15 | $204 |
| Losartan Potassium | 21 | $118 |
| Amlodipine Besylate | 11 | $97 |
| Furosemide | 16 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $97 | $22,39417 claims |
| PfizerEliquis | $127 | $13,92116 claims |
| AstraZenecaFarxiga | $224 | $8,85416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Abington
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.